DHR

Brief From our Editor -- Danaher (DHR) Stock.

Large-cap Industrials company Danaher has logged a -1.7% change today on a trading volume of 8. The average volume for the stock is 3,017,303.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. Based in Washington, United States the company has 61,000 full time employees and a market cap of $178,068,553,728. Danaher currently offers its equity investors a dividend that yields 0.4% per year.

The company is now trading -11.64% away from its average analyst target price of $272.09 per share. The 20 analysts following the stock have set target prices ranging from $220.0 to $297.0, and on average give Danaher a rating of buy.

Over the last 52 weeks, DHR stock has risen 14.2%, which amounts to a -9.6% difference compared to the S&P 500. The stock's 52 week high is $269.11 whereas its 52 week low is $182.09 per share. Based on Danaher's average net margin growth of 7.4% over the last 6 years, its core business is on track for profitability and its strong stock performance may continue in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 23,890,000 4,764,000 20 -25.93
2022 26,643,000 7,209,000 27 3.85
2021 24,802,000 6,433,000 26 62.5
2020 22,284,000 3,646,000 16 -5.88
2019 17,911,000 3,008,000 17 30.77
2018 19,893,000 2,651,000 13
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS